News Lipum AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 15:15:27 31/05/2024 BST			5-day change	1st Jan Change
6.85 ^SEK	+2.24%		+7.87%	+5.06%

05-06	Lipum Obtains SEK20 Million Loan from Flerie Invest	MT
04-02	Lipum Strengthens Its Protection of the Drug Candidate Sol-116 Through A Patent Application for Inflammation-Driven Cancer	CI

Lipum: A new approach to chronic inflammation	05-29	AQ
Lipum Q1 - Initiating preparations for phase II	05-28	AQ
Lipum AB – interim report Q1 for the period January-March 2024	05-28	AQ
BioStock: Flerie Invest continues to support Lipum	05-13	AQ
Lipum Obtains SEK20 Million Loan from Flerie Invest	05-06	MT
Lipum receives loan commitment of SEK 20 million	05-06	AQ
BioStock: Lipum's CEO looks ahead after the rights issue	04-26	AQ
Lipum announces final outcome of the rights issue	04-25	AQ
Lipum - Financed and ready to go	04-24	AQ
Lipum announces preliminary outcome of the rights issue	04-23	AQ
Lipum and NorthX Biologics enter into new strategic manufacturing alliance	04-18	AQ
Lipum has been granted funding from Swelife	04-12	AQ
Lipum publishes supplement to the prospectus regarding the rights issue	04-05	AQ
Lipum publishes prospectus regarding the rights issue	04-03	AQ
BioStock: Lipum seeks patent protecting inflammation-driven cancer treatment	04-03	AQ
Lipum AB - Report from the Extraordinary General Meeting	04-02	AQ
Lipum strengthens its protection of the drug candidate SOL-116 through a patent application for inflammation-driven cancer	04-02	AQ
Lipum Strengthens Its Protection of the Drug Candidate Sol-116 Through A Patent Application for Inflammation-Driven Cancer	04-02	CI
BioStock: Lipum has included first RA patient	03-22	AQ
Statement from the Board of Directors of Lipum regarding the mandatory public offer from Flerie Invest AB	03-20	AQ

No results for this search